Active control trials for epilepsy - Avoiding bias in head-to-head trials

被引：5
作者：
French, JA [1 ]
Kryscio, RJ
机构：
[1] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Kentucky, Dept Stat, Lexington, KY 40506 USA
[3] Univ Kentucky, Dept Biostat, Lexington, KY USA
来源：
NEUROLOGY | 2006年 / 66卷 / 09期
关键词：
D O I：
10.1212/01.wnl.0000218836.23697.f9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1294 / 1295
页数：2
相关论文
共 6 条
[1]   Idiopathic generalized epilepsy and choice of antiepileptic drugs [J].
Benbadis, SR ;
Tatum, WO ;
Gieron, M .
NEUROLOGY, 2003, 61 (12) :1793-1795
[2]   DOUBLE-BLIND COMPARISON OF LAMOTRIGINE AND CARBAMAZEPINE IN NEWLY-DIAGNOSED EPILEPSY [J].
BRODIE, MJ ;
RICHENS, A ;
YUEN, AWC .
LANCET, 1995, 345 (8948) :476-479
[3]   Concerns with antiepileptic drug initiation: Safety, tolerability and efficacy [J].
Ferrendelli, JA .
EPILEPSIA, 2001, 42 :28-30
[4]   A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy [J].
Gamble, C ;
Williamson, PR ;
Chadwick, DW ;
Marson, AG .
NEUROLOGY, 2006, 66 (09) :1310-1317
[5]  
MEINERT CL, 1986, CLIN TRIALS DESIGN C, P66
[6]  
Sachdeo RC, 1999, NEUROLOGY, V52, pA391
1